Martin D. Madaus - 04 Apr 2022 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
Director
Signature
/s/ Martin D. Madaus by Nicholas Khadder, Attorney-in-Fact
Issuer symbol
LAB
Transactions as of
04 Apr 2022
Transactions value $
$0
Form type
4
Filing time
06 Apr 2022, 18:35:07 UTC
Previous filing
05 Jan 2022
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock Award $0 +15.9K $0.00 15.9K 04 Apr 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Stock Option (Right to Buy) Award $0 +23.4K $0.00 23.4K 04 Apr 2022 Common Stock 23.4K $3.99 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units that vest in four equal annual installments beginning April 4, 2023.
F2 The Option becomes exercisable in four equal annual installments beginning on April 4, 2023.